Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) — Financial Flexibility Index
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (300534) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of CN¥-9.54 Million (operating CF CN¥-17.57 Million minus capex CN¥8.02 Million) represents 0% of total liabilities (CN¥567.12 Million). Check Gansu Longshenrongfa Pharmaceutical Indu total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd across 15 annual periods. For the full cash flow conversion analysis, see how efficiently does Gansu Longshenrongfa Pharmaceutical Indu generate cash.
Annual Financial Flexibility Index for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (2011–2025)
Year-by-year free cash flow to debt coverage for Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. Explore 300534 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥36.83 Million | CN¥-6.54 Million | CN¥613.42 Million | ▼ -83.7% |
| 2024 | 0.37x | CN¥248.36 Million | CN¥170.14 Million | CN¥674.39 Million | ▲ +3.3% |
| 2023 | 0.36x | CN¥222.89 Million | CN¥96.53 Million | CN¥625.14 Million | ▲ +113.0% |
| 2022 | 0.17x | CN¥25.05 Million | CN¥11.43 Million | CN¥149.66 Million | ▼ -70.4% |
| 2021 | 0.56x | CN¥51.55 Million | CN¥51.13 Million | CN¥91.24 Million | ▲ +16.1% |
| 2020 | 0.49x | CN¥62.05 Million | CN¥43.50 Million | CN¥127.53 Million | ▼ -38.9% |
| 2019 | 0.80x | CN¥56.73 Million | CN¥28.21 Million | CN¥71.26 Million | ▲ +253.0% |
| 2018 | 0.23x | CN¥13.01 Million | CN¥10.23 Million | CN¥57.68 Million | ▼ -70.6% |
| 2017 | 0.77x | CN¥53.67 Million | CN¥-2.05 Million | CN¥70.04 Million | ▼ -30.8% |
| 2016 | 1.11x | CN¥66.17 Million | CN¥13.14 Million | CN¥59.74 Million | ▲ +36.8% |
| 2015 | 0.81x | CN¥195.26 Million | CN¥30.60 Million | CN¥241.17 Million | ▼ -32.5% |
| 2014 | 1.20x | CN¥138.36 Million | CN¥39.01 Million | CN¥115.40 Million | ▲ +67.2% |
| 2013 | 0.72x | CN¥96.86 Million | CN¥35.92 Million | CN¥135.04 Million | ▲ +47.7% |
| 2012 | 0.49x | CN¥59.78 Million | CN¥35.62 Million | CN¥123.07 Million | ▲ +63.2% |
| 2011 | 0.30x | CN¥22.37 Million | CN¥10.16 Million | CN¥75.15 Million | — |